These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 36892041)

  • 1. Myocardial Revascularization in Patients With Ischemic Cardiomyopathy: For Whom and How.
    Liga R; Colli A; Taggart DP; Boden WE; De Caterina R
    J Am Heart Assoc; 2023 Mar; 12(6):e026943. PubMed ID: 36892041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Percutaneous Revascularization for Ischemic Ventricular Dysfunction: Rationale and Design of the REVIVED-BCIS2 Trial: Percutaneous Coronary Intervention for Ischemic Cardiomyopathy.
    Perera D; Clayton T; Petrie MC; Greenwood JP; O'Kane PD; Evans R; Sculpher M; Mcdonagh T; Gershlick A; de Belder M; Redwood S; Carr-White G; Marber M;
    JACC Heart Fail; 2018 Jun; 6(6):517-526. PubMed ID: 29852933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coronary revascularisation in patients with ischaemic cardiomyopathy.
    Ryan M; Morgan H; Petrie MC; Perera D
    Heart; 2021 Apr; 107(8):612-618. PubMed ID: 33436491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Anatomical and Viability-Guided Completeness of Revascularization on Clinical Outcomes in Ischemic Cardiomyopathy.
    Ezad SM; McEntegart M; Dodd M; Didagelos M; Sidik N; Li Kam Wa M; Morgan HP; Pavlidis A; Weerackody R; Walsh SJ; Spratt JC; Strange J; Ludman P; Chiribiri A; Clayton T; Petrie MC; O'Kane P; Perera D;
    J Am Coll Cardiol; 2024 Jul; 84(4):340-350. PubMed ID: 38759904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypotheses, rationale, design, and methods for prognostic evaluation of a randomized comparison between patients with coronary artery disease associated with ischemic cardiomyopathy who undergo medical or surgical treatment: MASS-VI (HF).
    Rezende PC; Hueb W; Bocchi EA; Farkouh M; Junior CVS; Lima EG; Silva EER; Dallan LAO; Gaiotto FA; Garzillo CL; Rochitte CE; Nomura CH; Scudeler TL; Soares PR; Jatene FB; Ramires JAF; Filho RK
    Trials; 2020 Apr; 21(1):337. PubMed ID: 32299458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocardial viability assessment and utility in contemporary management of ischemic cardiomyopathy.
    Katikireddy CK; Samim A
    Clin Cardiol; 2022 Feb; 45(2):152-161. PubMed ID: 35077580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of Percutaneous Revascularization in Severe Ischemic Left Ventricular Dysfunction.
    Bista R; Zghouzi M; Jasti M; Lichaa H; Kerrigan J; Haddad E; Alraies MC; Paul TK
    Curr Cardiol Rep; 2024 May; 26(5):435-442. PubMed ID: 38642298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positron emission tomography for the assessment of myocardial viability: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2005; 5(16):1-167. PubMed ID: 23074467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Ischemic cardiomyopathy: possibilities of surgical treatment].
    Benetis R; Simukauskiene A; Jankauskiene L; Kavoliūniene A
    Medicina (Kaunas); 2007; 43(11):909-17. PubMed ID: 18084150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Revascularization in heart failure in the post-STICH era.
    Jha S; Flamm SD; Kwon DH
    Curr Heart Fail Rep; 2013 Dec; 10(4):365-72. PubMed ID: 24142670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Current Role of Viability Imaging to Guide Revascularization and Therapy Decisions in Patients With Heart Failure and Reduced Left Ventricular Function.
    Kandolin RM; Wiefels CC; Mesquita CT; Chong AY; Boland P; Glineur D; Sun L; Beanlands RS; Mielniczuk LM
    Can J Cardiol; 2019 Aug; 35(8):1015-1029. PubMed ID: 31376903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alternative Imaging Modalities in Ischemic Heart Failure (AIMI-HF) IMAGE HF Project I-A: study protocol for a randomized controlled trial.
    O'Meara E; Mielniczuk LM; Wells GA; deKemp RA; Klein R; Coyle D; Mc Ardle B; Paterson I; White JA; Arnold M; Friedrich MG; Larose E; Dick A; Chow B; Dennie C; Haddad H; Ruddy T; Ukkonen H; Wisenberg G; Cantin B; Pibarot P; Freeman M; Turcotte E; Connelly K; Clarke J; Williams K; Racine N; Garrard L; Tardif JC; DaSilva J; Knuuti J; Beanlands R;
    Trials; 2013 Jul; 14():218. PubMed ID: 23866673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of viability imaging in the post-STICH era.
    Shah BN; Senior R
    Curr Opin Cardiol; 2014 Mar; 29(2):145-51. PubMed ID: 24385081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between myocardial perfusion-gated SPECT and the performance of coronary revascularization in patients with ischemic cardiomyopathy.
    Romero-Farina G; Candell-Riera J; Aguadé-Bruix S; Ferreira-Gonzalez I; Igual A; García-Dorado D
    Clin Nucl Med; 2012 Oct; 37(10):965-70. PubMed ID: 22955070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The benefits of revascularization in chronic heart failure.
    Gurunathan S; Ahmed A; Senior R
    Curr Heart Fail Rep; 2015 Apr; 12(2):112-9. PubMed ID: 25500783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Viability and Outcomes With Revascularization or Medical Therapy in Ischemic Ventricular Dysfunction: A Prespecified Secondary Analysis of the REVIVED-BCIS2 Trial.
    Perera D; Ryan M; Morgan HP; Greenwood JP; Petrie MC; Dodd M; Weerackody R; O'Kane PD; Masci PG; Nazir MS; Papachristidis A; Chahal N; Khattar R; Ezad SM; Kapetanakis S; Dixon LJ; De Silva K; McDiarmid AK; Marber MS; McDonagh T; McCann GP; Clayton TC; Senior R; Chiribiri A;
    JAMA Cardiol; 2023 Dec; 8(12):1154-1161. PubMed ID: 37878295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The rationale and design of the Surgical Treatment for Ischemic Heart Failure (STICH) trial.
    Velazquez EJ; Lee KL; O'Connor CM; Oh JK; Bonow RO; Pohost GM; Feldman AM; Mark DB; Panza JA; Sopko G; Rouleau JL; Jones RH;
    J Thorac Cardiovasc Surg; 2007 Dec; 134(6):1540-7. PubMed ID: 18023680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of revascularization to improve left ventricular function.
    Patel HC; Ellis SG
    Heart Fail Clin; 2015 Apr; 11(2):203-14. PubMed ID: 25834970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extent of coronary and myocardial disease and benefit from surgical revascularization in ischemic LV dysfunction [Corrected].
    Panza JA; Velazquez EJ; She L; Smith PK; Nicolau JC; Favaloro RR; Gradinac S; Chrzanowski L; Prabhakaran D; Howlett JG; Jasinski M; Hill JA; Szwed H; Larbalestier R; Desvigne-Nickens P; Jones RH; Lee KL; Rouleau JL
    J Am Coll Cardiol; 2014 Aug; 64(6):553-61. PubMed ID: 25104523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low dose wall motion score predicts the short and long-term benefit of surgical revascularization in patients with ischemic left ventricular dysfunction.
    Abdul Ghaffar Y; Maskoun W; Mustafa NG; Feigenbaum H; Sawada SG
    Int J Cardiovasc Imaging; 2019 Sep; 35(9):1651-1659. PubMed ID: 31053980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.